Answer
The immunosuppressive effects of fingolimod hydrochloride increase the risk of lymphomas and other malignancies, particularly skin malignancies.
Sources for this answer
- Gilenya 0.25mg and 0.5mg hard capsulesNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 37Document updated
Sources checked